Soluble TNF-Like Weak Inducer of Apoptosis as a New Marker in Preeclampsia: A Pilot Clinical Study

Table 1

Comparison of the groups regarding clinical characteristics.

	Patient ()		Control ()		value
	Mean ± SD	Min–Max	Mean ± SD	Min–Max
Age (years)	29.3 ± 4.9	18–39	28.4 ± 5.0	18–40	0.51
Weight (kg)	77.9 ± 15.1	60–130	75.4 ± 12.7	56–106	0.49
Height (cm)	159 ± 6	145–173	161 ± 5	151–169	0.38
Gravidity ()	2.2 ± 1.4	1–8	2.2 ± 0.9	1–4	0.77
Parity ()	0.9 ± 1.2	0–6	0.9 ± 0.7	0–2	0.71
Abortus ()	0.2 ± 0.5	0–2	0.3 ± 0.5	0–2	0.30
Systolic BP (mmHg)	156 ± 19	128–200	109 ± 14	82–138	<0.001
Diastolic BP (mmHg)	97 ± 13	72–138	70 ± 11	46–94	<0.001
Gestational week at birth	34 ± 4	26–39	39 ± 1	38–94	<0.001
Birth weight (g)	2159 ± 964	470–3750	3375 ± 426	2570–4060	<0.001